Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Interstitial

Explore clinical trials studying Lung Diseases, Interstitial. Study availability and eligibility vary by location and protocol.

725 public trials 132 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Interstitial trial results

Completed

Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis

NCT02888080

Conditions
Autoimmune Diseases, Granuloma, Hemic and Lymphatic Diseases, +14 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Albany, New York, United States
  • Novartis Investigative Site Cleveland, Ohio, United States
  • Novartis Investigative Site Essen, Germany
View Trial Details
Completed

Nutritional Assessment in Idiopathic Pulmonary Fibrosis

NCT03770845

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • INRCA Casatenovo Casatenovo, Lecco, Italy
  • San Gerardo Hospital Monza, MB, Italy
  • G. Salvini Hospital Garbagnate Milanese, Milano, Italy
  • Ospedale di Circolo Busto Arsizio, Varese, Italy
View Trial Details
Completed

A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT03725852

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Specialized Hospital for Active Treatment Pleven Pleven, Bulgaria
  • SHATPPD Dr. Dimitar Gramatikov, Ruse Ltd. Rousse, Bulgaria
  • Acibadem City Clinic Tokuda Hospital, EAD Sofia, Bulgaria
  • Klinicki Bolnicki Centar Rijeka - Susak Rijeka, Croatia
View all 36 locations
View Trial Details

Related conditions